Effects of chitosan on serum cytokine levels in elderly subjects

Archives of Pharmacal Research

Volumn 30, Issue 12, 2007, Pages 1550-1557

  Kyung, Sin Baek ^a   Eun, Kyung Won ^a   Se, Young Choung ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Chitosan; Cytokine; Elderly adults; Health function food; Immune enhancing activity

Indexed keywords

EID: 38049144299     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02977324     Document Type: Article

References (40)

1. Amiji, M. M., Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for haemodialysis. Biomaterials., 16, 593-599 (1995).
2. Basaran, Y., Basaran, M. M., Babacan, K. F., Ener, B., Okay, T., and Gok, H., Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology., 44, 332-337 (1993).
3. Basso, D., Scrigner, M., Toma, A., Navaglia, F., and DiMario, F., Helicobacter pylori infection enhances mucosal interleukin-1beta, interleukin-6, and the soluble receptor of interleukin-2. Int J. Clin.Lab. Res., 26,207-210(1996).
4. Benesch, J. and Tengvall, P., Blood protein adsorption onto chitosan. Biomaterials., 23, 2561-2568 (2002).
5. Burger, R. A., Torres, A. R., Warren, R. P., Caldwell, V. D., and Hughes, B. G., Echinacea-induced cytokine production by human macrophages. Int. J. Immunopharmacol., 19, 371-379 (1997).
6. Casswall, T. H., Nilsson, H. O., Bjorck, L., Sjostedt, S., Xu, L., Nord, C. K., Boren, T., Wadstrom, T., and Hammarstrom, L., Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J. Gastroenterol., 37, 1380-1385 (2002).
7. Chehimi, J. and Trinchieri, G., Interleukin-12:a brige between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol., 14, 149-161 (1994).
8. Chou, T. C., Fu, E., and Shen, E. C., Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun., 308, 403-407 (2003).
9. Dautremepuits, C., Betoulle, S., Paris-Palacios, S., and Vernet, G., Humoral immune factors modulated by copper and chitosan in healthy or parasitised carp (Cyprinus carpio L.) by Ptychobothrium sp. (Cestoda). Aquat Toxicol., 68, 325-338 (2004).
10. Dautremepuits, C., Betoulle, S., Paris-Palacios, S., and Vernet, G., Immunology-related perturbations induced by copper and chitosan in carp (Cyprinus carpio L.). Arch. Environ. Contam. Toxicol., 47, 370-378 (2004).
11. Ebihara, K. and Schneeman, B. O., Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J. Nutr., 119, 1100-1106 (1989).
12. Fukada, Y., Kimura, K., and Ayaki, Y., Effect of chitosan feeding on intestinal bile acid metabolism in rats. Lipids, 26, 395-399 (1991).
13. Gallucci, R. M., Simeonova, P. P., Matheson, J. M., Kommineni, C., Guriel, J. L., Sugawara, T., and Luster, M. I., Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J., 14, 2525-2531 (2000).
14. Gupta, S., Kim, S. K., Vemuru, R. P., Aragona, E., Yerneni, P. R., Burk, R. D., and Rha, C. K., Hepatocyte transplantation: an alternative system for evaluating cell survival and immunoisolation. Int. J. Artif. Organs, 16, 155-163 (1993).
15. Han, L. K., Kimura, Y., and Okuda, H., Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int J. Obes. Relat. Metab. Disord., 23, 174-179 (1999).
16. Jain, J., Loh, C., and Rao, A., Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol., 7, 333-342 (1998).
17. Jing, S. B., Li, L., and Ji, D., Effect of chitosan on renal function in patients with chronic renal failure. J. Pharm. Pharmacol., 49, 721-723 (1997).
18. Jung, H. C., Kim, J. M., Song, I. S., and Kim, C. Y., Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells:quantification of mRNA for interleukine-8,-1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and timour necrosis factor alpha. J. Gastroenterol Hepatol., 12, 473-480 (1997).
19. Lee, J. K., Kim, S. U., and Kim, J. H., Modification of chitosan to improve its hypocholesterolemic capacity. Biosci. Biotechnol. Biochem., 63, 833-839 (1999).
20. Lehoux, J. G. and Grondin, F.. Some effects of chitosan on liver function in the rat. Endocrinology, 132, 1078-1084 (1993).
21. Maury, C. P. and Teppo, A. M., Circulating tumour necrosis factoralpha (cachetin) in myocardial infarction. J. Intern. Med., 225, 333-336 (1989).
22. Miura, T., Usami, M., and Tsuura, Y., Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotacin-induced diabetic mice. Biol. Pharm. Bull., 18,1 623-1625 (1995).
23. Nagano, N., Yoshimoto, H., and Nishitoba, T., Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (II). Effect of chitosan DAC on rats with chronic renal failure induced by adriamycin. Nippon. Yakurigaku Zasshi., 106, 123-133 (1995).
24. Nechaeva, E., Development of oral microencapsulated forms for delivering viral vaccines. Expert. Rev. Vaccines, 1, 385-397 (2002).
25. Noach, L. A., Bosma, N. B., Jansen, J., Hoek, F. J., van Deventer, S. J., and Tytgat, G. N., Mucosal tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J. Gastroenterol., 29, 425-429 (1994).
26. Omrod, D. J., Holmes, C. C., and Miller, T. E., Dietary chitosan inhibits hypercholesterolcemia and atherosclerosis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis., 138, 329-334 (1998).
27. Percival, S. S., Use of echinacea in medicine. Biochem Pharmacol., 60, 155-158 (2000).
28. Pittler, M. H., Abbot, N. C., Harkness, E. F., and Ernst, E., Randomized, double-blind trial of chitosan for body weight reduction. Eur. J. Clin. Nutr., 53, 379-381 (1999).
29. Porporatto, C., Bianco, I. D., Cabanillas, A. M., and Correa, S. G., Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines. Int. Immunol., 16, 433-441 (2004).
30. Rosales-Cortes, M., Peregrina-Sandoval, J., Banuelos-Pineda, J., Sarabia-Estrada, R., Gomez-Rodiles, C. C., Albarran-Rodriguez, E., Zaitseva, G. P., Pita-Lopez, M. L., Immunological study of a chitosan prosthesis in the sciatic nerve regeneration of the axotomized dog. J. Biomater. Appl., 18,15-23 (2003).
31. Ryu, B.-H., Inhibitory Effects of Tumor Metastasis by Chitosan Derivative, of Sulfated N-acetyl Chitosan. Korean J. Biotechnol. Bioengin., 10, 525-532 (1995).
32. Ryu, B.-H., Antitumor and immunologic activity of chitosan extracted from shell of shrimp. J. Korean Soc. Food Nutr., 21, 154-162 (1992).
33. Salmon-Her, V., Ramont, L., Godeau, G., Birembaut, P., Guenounou, M., Bernard, P., and Maquart, F. X., Implication of interleukin-4 in wound healing. Lab. Invest., 80, 1337-1344 (2000).
34. Sorlier, P., Hartmann, D. J., Denuziere, A., Viton, C., and Domard, A., Preparation and development of anti-chitosan antibodies. J. Biomed. Mater. Res., 67A, 766-774 (2003).
35. Sugano, M., Watanabe, S., and Kishi, A., Hypocholesterolemic action of chitosans with different viscosity in rats. Lipids., 23, 187-191 (1988).
36. Sun, C. J., Pan, S. P., Xie, Q. X., and Xiao, L. J., Preparation of chitosan-plasmid DNA nanoparticles encoding zona pelluci da glycoprotein-3alpha and its expression in mouse. Mol. Reprod. Dev., 68, 182-188 (2004).
37. Vasyukova, N. I., Zinov'eva, S. V., Udalova, Zh. V., Panina, Y. S., Ozeretskovskaya, O. L., and Sonin, M. D., The role of salicylic acid in systemic resistance of tomato to nematodes. Dokl. Biol. Sci., 391, 343-345 (2003).
38. Woo, C. J. and Park, H. D., An extracellular Bacillus sp. chitinase for the production of chitotriose as a major chitinolytic product. Biotechnol Lett., 25, 409-412 (2003).
39. Wuolijoki, E., Hirvela, T., and Ylitalo, P., Decrease in LDL-cholesterol with microcrystalline chitosan. Methods Find. Exp. Clin. Pharmacol., 21, 357-361 (1999).
40. Yoshimoto, H., Nagano, N., and Nishitoba, N., Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC), a newly developed oral adsorbent (I). Effect of chitosan DAC in normal rats. Nippon Yakurigaku Zasshi., 106, 113-122 (1995).